Related Articles
The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer
Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade